BCRX
BioCryst Pharmaceuticals, Inc. · Healthcare
Director Machelle Sanders sold $28K of BioCryst Pharmaceuticals, Inc.
Sold$28,134
$6.00Price
4,689Shares
−14%Stake
What BCRX did after the filing
- The stock from Mon, Jun 17 close, $6.24
- +16.7%
- S&P 500, same days
- +1.0%
Measured over 30 trading days, to the Jul 31 close.
Traded Mon, Jun 17. Filed Mon, Jun 17, 12:31 PM ET, during the session. Returns use the Jun 17 close and the Jul 31 close. Not investment advice.